Food and Drug Law Journal
Author | : |
Publisher | : |
Total Pages | : 692 |
Release | : 1914 |
Genre | : Cosmetics |
ISBN | : |
Download Food and Drug Law Journal Book in PDF, ePub and Kindle
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Food And Drug Law Journal PDF full book. Access full book title Food And Drug Law Journal.
Author | : |
Publisher | : |
Total Pages | : 692 |
Release | : 1914 |
Genre | : Cosmetics |
ISBN | : |
Author | : |
Publisher | : |
Total Pages | : 1182 |
Release | : 1991 |
Genre | : Cosmetics |
ISBN | : |
Author | : Stephen M. Kanovsky |
Publisher | : |
Total Pages | : 672 |
Release | : 2020-09 |
Genre | : Drugs |
ISBN | : 9781935065876 |
FDLI's popular reference book, A Practical Guide to FDA's Food and Drug Law and Regulation, Seventh Edition, provides an introduction to the laws and regulations governing development, marketing, and sale of FDA-regulated products, including topics on food, drugs, medical devices, biologics, dietary supplements, cosmetics, new animal drugs, cannabis, and tobacco and nicotine products. Structured to serve as a reference and as a teaching tool, the book offers practical legal and regulatory fundamentals, and each chapter builds sequentially from the last to provide an accessible overview of the key topics relevant to practitioners of food and drug law and regulation. This book is a standard legal text in law schools and graduate regulatory programs and has been cited as a reference in judicial opinions (including the U.S. Supreme Court). This Seventh Edition includes new sections on controlled substances, compounded drugs, and cannabis and cannabis-derived compounds. It also incorporates the latest amendments to the Federal Food, Drug, and Cosmetic Act, as well as FDA regulations and guidances.
Author | : Holly Fernandez Lynch |
Publisher | : Columbia University Press |
Total Pages | : 499 |
Release | : 2015-09-08 |
Genre | : Business & Economics |
ISBN | : 0231540078 |
In its decades-long effort to assure the safety, efficacy, and security of medicines and other products, the Food and Drug Administration has struggled with issues of funding, proper associations with industry, and the balance between consumer choice and consumer protection. Today, these challenges are compounded by the pressures of globalization, the introduction of novel technologies, and fast-evolving threats to public health. With essays by leading scholars and government and private-industry experts, FDA in the Twenty-First Century addresses perennial and new problems and the improvements the agency can make to better serve the public good. The collection features essays on effective regulation in an era of globalization, consumer empowerment, and comparative effectiveness, as well as questions of data transparency, conflicts of interest, industry responsibility, and innovation policy, all with an emphasis on pharmaceuticals. The book also intervenes in the debate over off-label drug marketing and the proper role of the FDA before and after a drug goes on the market. Dealing honestly and thoroughly with the FDA's successes and failures, these essays rethink the structure, function, and future of the agency and the effect policy innovations may have on regulatory institutions abroad.
Author | : Mikkael A. Sekeres |
Publisher | : MIT Press |
Total Pages | : 319 |
Release | : 2024-02-06 |
Genre | : Medical |
ISBN | : 0262548399 |
How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin. Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer’s drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate US authority on a drug’s safety and efficacy? In Drugs and the FDA, Mikkael Sekeres—a leading oncologist and former chair of the FDA’s cancer drug advisory committee—tells the story of how the FDA became the most trusted regulatory agency in the world. It took a series of tragedies and health crises, as well as patient advocacy, for the government to take responsibility for ensuring the efficacy and safety of drugs and medical devices. Before the FDA existed, drug makers could hawk any potion, claim treatment of any ailment, and make any promise on a label. But then, throughout the twentieth century, the government was forced to take action when children were poisoned by contaminated diphtheria and smallpox vaccines, an early antibiotic contained antifreeze, a drug prescribed for morning sickness in pregnancy caused babies to be born disfigured, and access to AIDS drugs was limited to a few clinical trials while thousands died. Sekeres describes all these events against the backdrop of the contentious 2011 hearings on the breast cancer drug Avastin, in which he participated as a panel member. The Avastin hearings, he says, put to the test a century of the FDA’s evolution, demonstrating how its system of checks and balances works—or doesn’t work.
Author | : Jeffrey Gibbs |
Publisher | : |
Total Pages | : |
Release | : 2020-12-20 |
Genre | : |
ISBN | : 9781935065890 |
Author | : Peter Barton Hutt |
Publisher | : |
Total Pages | : 372 |
Release | : 1998 |
Genre | : Drugs |
ISBN | : |
A well written and organized yellow pages (literally) resource guide for K-12 educators to help them maximize Internet benefits in their curriculum. The manual features Internet basics: how e-mail, netnews, mailing lists, and the world wide web works; what information is available, and how to access it. The directory covers Internet resources in 40 curriculum areas, sub-divided by type of Internet application or tool, and a listing of general education projects for school administrators. Annotation copyright by Book News, Inc., Portland, OR
Author | : |
Publisher | : |
Total Pages | : |
Release | : 2005 |
Genre | : |
ISBN | : |
Author | : National Research Council |
Publisher | : National Academies Press |
Total Pages | : 589 |
Release | : 2010-11-04 |
Genre | : Medical |
ISBN | : 0309163587 |
Recent outbreaks of illnesses traced to contaminated sprouts and lettuce illustrate the holes that exist in the system for monitoring problems and preventing foodborne diseases. Although it is not solely responsible for ensuring the safety of the nation's food supply, the U.S. Food and Drug Administration (FDA) oversees monitoring and intervention for 80 percent of the food supply. The U.S. Food and Drug Administration's abilities to discover potential threats to food safety and prevent outbreaks of foodborne illness are hampered by impediments to efficient use of its limited resources and a piecemeal approach to gathering and using information on risks. Enhancing Food Safety: The Role of the Food and Drug Administration, a new book from the Institute of Medicine and the National Research Council, responds to a congressional request for recommendations on how to close gaps in FDA's food safety systems. Enhancing Food Safety begins with a brief review of the Food Protection Plan (FPP), FDA's food safety philosophy developed in 2007. The lack of sufficient detail and specific strategies in the FPP renders it ineffectual. The book stresses the need for FPP to evolve and be supported by the type of strategic planning described in these pages. It also explores the development and implementation of a stronger, more effective food safety system built on a risk-based approach to food safety management. Conclusions and recommendations include adopting a risk-based decision-making approach to food safety; creating a data surveillance and research infrastructure; integrating federal, state, and local government food safety programs; enhancing efficiency of inspections; and more. Although food safety is the responsibility of everyone, from producers to consumers, the FDA and other regulatory agencies have an essential role. In many instances, the FDA must carry out this responsibility against a backdrop of multiple stakeholder interests, inadequate resources, and competing priorities. Of interest to the food production industry, consumer advocacy groups, health care professionals, and others, Enhancing Food Safety provides the FDA and Congress with a course of action that will enable the agency to become more efficient and effective in carrying out its food safety mission in a rapidly changing world.
Author | : Emily Strunk |
Publisher | : |
Total Pages | : |
Release | : 2021-05-31 |
Genre | : |
ISBN | : 9781935065937 |
The FDCA Statutory Supplement, 2021 is an indispensable tool for FDA law practitioners. This publication provides cross-referencing of the numerous legislative amendments with the original statute, facilitating quick research and citation, and highlights recent changes through simple formatting. This edition is updated to incorporate the CARES Act and other statutory amendments since the 2018 edition. The appendix contains relevant portions of related statutes. This publication is available in both print and E-book versions.